IRF1 has tumor suppressor [31,32] and antimicrobial functions [33], whereas IRF7 is required for the activation of the IFN-α and -λ gene transcription that, as mentioned before, requires the IRF3-IRF7 activated heterodimers. The gene discussed is IRF7; the disease is neoplasm.